NASDAQ · Medical - Devices

InspireMD Inc. (NSPR) Stock

$0.52 +8.54% NASDAQ: NSPR Healthcare

Valuation

MetricValue
Price$0.52
Market Cap$24.40M
P/E Ratio-1.17
P/B Ratio1.35
P/S Ratio2.51
EPS (TTM)$-0.61
52-Week High$2.93
52-Week Low$0.47
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-79.21%
ROA-86.25%
ROCE-153.04%
Gross Margin28.06%
Operating Margin-4.81%
Net Margin-355.17%
Debt/Equity0.06
Current Ratio5.55

Annual Financials (USD)

Metric20212022202320242025
Revenue$4.0M$5.0M$6.0M$7.0M$9.0M
Operating Profit$-15.0M$-19.0M$-21.0M$-34.0M$-49.0M
Net Profit$-15.0M$-18.0M$-20.0M$-32.0M$-49.0M
EPS$-2.03$-2.35$-0.82$-0.76$-0.76
Op Margin-327.4%-361.9%-340.7%-478.0%-547.0%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$40.0M$25.0M$48.0M$47.0M$69.0M
Total Liabilities$6.0M$7.0M$8.0M$11.0M$14.0M
Cash$12.0M$5.0M$10.0M$19.0M$9.0M
Borrowings$1.0M$2.0M$2.0M$2.0M$3.0M

Latest News

InspireMD Posts Positive CGUARDIANS II Data for CGuard Prime TCAR Zacks · Jun 16, 2026 InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire · Jun 12, 2026 InspireMD Announces 30-Day Results from the CGUARDIANS II Clinical Trial of the CGuard Prime 80 cm Implant for Use in TCAR Procedures GlobeNewswire · Jun 11, 2026 InspireMD Announces First Patient Enrolled in the CGUARDIANS III Pivotal Study of the SwitchGuard Neuro Protection System for Use in TCAR Procedures GlobeNewswire · Jun 8, 2026 InspireMD to Participate in Upcoming Bank of America Securities 2026 Global Healthcare Conference GlobeNewswire · May 6, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-13.0M$-16.0M$-16.0M$-22.0M$-35.0M
Investing Cash Flow$-23.0M$8.0M$-16.0M$11.0M$-32.0M
Financing Cash Flow$0$0$0$17.0M$0
Net Cash Flow$-1.0M$-7.0M$5.0M$9.0M$-10.0M
Free Cash Flow$-14.0M$-16.0M$-17.0M$-23.0M$-37.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.02
EV / EBITDA-0.37
FCF Yield-156.27%
Quick Ratio3.52
Interest Coverage0.00
Return 1Y-68.70%
Return 3Y-77.14%
Return 5Y-83.33%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $336.64 -1.11% 38.93 $4.94T 0.32%
MSFTMicrosoft Corporation $535.07 +2.38% 28.68 $3.97T 0.76%
GOOGLAlphabet Inc. $351.66 +0.97% 16.94 $4.26T 0.26%
AMZNAmazon.com, Inc. $262.43 +3.29% 19.82 $2.82T 0.00%
METAMeta Platforms, Inc. $718.67 -0.31% 27.93 $1.83T 0.28%

About InspireMD Inc.

InspireMD Inc. is led by CEO Marvin L. Slosman, employs 85 people, headquartered in IL, publicly traded since 2011.

InspireMD Inc. (NSPR) stock trades at $0.52 with a market capitalization of $24.40M. The stock is valued at a price-to-earnings (P/E) ratio of -1.17, price-to-book of 1.35, price-to-sales of 2.51. Over the past 52 weeks the stock has ranged between $0.47 and $2.93, and currently trades 82.3% below its 52-week high.

On profitability, InspireMD Inc. generates a return on equity (ROE) of -79.21%, return on capital employed of -153.04%, an operating margin of -4.81%, a net profit margin of -355.17%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.31 +0.33% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides